On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against cancer-causing HPV in China, which previously powered Merck’s growth.

Cervical cancer constitutes a formidable health challenge imperiling the well-being and lives of women globally, particularly in underdeveloped nations. The survival rates among patients diagnosed ...

Global disparities exist in the burden of cervical cancer. Only 11 out of the 185 countries and regions reported an age-standardized incidence rates (ASIR) lower than the World Health Organization’s ...

Cervical cancer rates are on the rise among younger women, owing in part to a lack of awareness, screening and prevention. A new study found that the percentage of women screened for cervical ...

haematobium), a parasitic infection affecting millions globally, can trigger cancer-related gene activity in the cervical lining, with changes becoming even more pronounced after treatment.